Global Neostigmine Methylsulfate Injection Market Research Report 2025(Status and Outlook)

March 2025 | 244 pages | ID: GDCF9EC3AD49EN
Bosson Research

Abstracts

Report Overview

It is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage

This report provides a deep insight into the global Neostigmine Methylsulfate Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neostigmine Methylsulfate Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neostigmine Methylsulfate Injection market in any manner.

Global Neostigmine Methylsulfate Injection Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

SPH

Jiuxu Pharma

Ronghong Pharma

Xianju Pharma

Pujing Pharma

Dr. Reddy's

Swiss

Daiichi Sankyo

Amneal Pharma

Amphastar Pharmaceuticals

Amring Pharma

BE Pharmaceuticals

Biological E

Caplin Point Laboratories

Exela Pharma

Yifan Pharmaceutical

Market Segmentation (by Type)

0.5Mg/Ml

1Mg/Ml

Market Segmentation (by Application)

Patients with Myasthenia Gravis

Acute Colonic Pseudo-obstruction

Ogway Syndrome

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Neostigmine Methylsulfate Injection Market
• Overview of the regional outlook of the Neostigmine Methylsulfate Injection Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neostigmine Methylsulfate Injection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Neostigmine Methylsulfate Injection
1.2 Key Market Segments
  1.2.1 Neostigmine Methylsulfate Injection Segment by Type
  1.2.2 Neostigmine Methylsulfate Injection Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL NEOSTIGMINE METHYLSULFATE INJECTION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Neostigmine Methylsulfate Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Neostigmine Methylsulfate Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL NEOSTIGMINE METHYLSULFATE INJECTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Neostigmine Methylsulfate Injection Product Life Cycle
3.3 Global Neostigmine Methylsulfate Injection Sales by Manufacturers (2020-2025)
3.4 Global Neostigmine Methylsulfate Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Neostigmine Methylsulfate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neostigmine Methylsulfate Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Neostigmine Methylsulfate Injection Manufacturing Sites, Area Served, Product Type
3.8 Neostigmine Methylsulfate Injection Market Competitive Situation and Trends
  3.8.1 Neostigmine Methylsulfate Injection Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Neostigmine Methylsulfate Injection Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NEOSTIGMINE METHYLSULFATE INJECTION INDUSTRY CHAIN ANALYSIS

4.1 Neostigmine Methylsulfate Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NEOSTIGMINE METHYLSULFATE INJECTION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Neostigmine Methylsulfate Injection Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Neostigmine Methylsulfate Injection Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL NEOSTIGMINE METHYLSULFATE INJECTION MARKET BY REGION

6.1 Global Neostigmine Methylsulfate Injection Market Size by Region
  6.1.1 Global Neostigmine Methylsulfate Injection Market Size by Region
  6.1.2 Global Neostigmine Methylsulfate Injection Market Size Market Share by Region
6.2 Global Neostigmine Methylsulfate Injection Sales by Region
  6.2.1 Global Neostigmine Methylsulfate Injection Sales by Region
  6.2.2 Global Neostigmine Methylsulfate Injection Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Neostigmine Methylsulfate Injection Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Neostigmine Methylsulfate Injection Market Size by Type
7.3 North America Neostigmine Methylsulfate Injection Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Neostigmine Methylsulfate Injection Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Neostigmine Methylsulfate Injection Market Size by Type
8.3 Europe Neostigmine Methylsulfate Injection Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Type
9.3 Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Neostigmine Methylsulfate Injection Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Neostigmine Methylsulfate Injection Market Size by Type
10.3 South America Neostigmine Methylsulfate Injection Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Type
11.3 Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Application

12 NEOSTIGMINE METHYLSULFATE INJECTION MARKET PRODUCTION BY REGION

12.1 Global Production of Neostigmine Methylsulfate Injection by Region(2020-2025)
12.2 Global Neostigmine Methylsulfate Injection Revenue Market Share by Region (2020-2025)
12.3 Global Neostigmine Methylsulfate Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Neostigmine Methylsulfate Injection Production
  12.4.1 North America Neostigmine Methylsulfate Injection Production Growth Rate (2020-2025)
  12.4.2 North America Neostigmine Methylsulfate Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Neostigmine Methylsulfate Injection Production
  12.5.1 Europe Neostigmine Methylsulfate Injection Production Growth Rate (2020-2025)
  12.5.2 Europe Neostigmine Methylsulfate Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Neostigmine Methylsulfate Injection Production (2020-2025)
  12.6.1 Japan Neostigmine Methylsulfate Injection Production Growth Rate (2020-2025)
  12.6.2 Japan Neostigmine Methylsulfate Injection Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Neostigmine Methylsulfate Injection Production (2020-2025)
  12.7.1 China Neostigmine Methylsulfate Injection Production Growth Rate (2020-2025)
  12.7.2 China Neostigmine Methylsulfate Injection Production, Revenue, Price and Gross Margin (2020-2025)

13 NEOSTIGMINE METHYLSULFATE INJECTION MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Neostigmine Methylsulfate Injection Sales Market Share by Type (2020-2033)
13.3 Global Neostigmine Methylsulfate Injection Market Size Market Share by Type (2020-2033)
13.4 Global Neostigmine Methylsulfate Injection Price by Type (2020-2033)

14 NEOSTIGMINE METHYLSULFATE INJECTION MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Neostigmine Methylsulfate Injection Market Sales by Application (2020-2033)
14.3 Global Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2033)
14.4 Global Neostigmine Methylsulfate Injection Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 SPH
  15.1.1 SPH Basic Information
  15.1.2 SPH Neostigmine Methylsulfate Injection Product Overview
  15.1.3 SPH Neostigmine Methylsulfate Injection Product Market Performance
  15.1.4 SPH Business Overview
  15.1.5 SPH SWOT Analysis
  15.1.6 SPH Recent Developments
15.2 Jiuxu Pharma
  15.2.1 Jiuxu Pharma Basic Information
  15.2.2 Jiuxu Pharma Neostigmine Methylsulfate Injection Product Overview
  15.2.3 Jiuxu Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.2.4 Jiuxu Pharma Business Overview
  15.2.5 Jiuxu Pharma SWOT Analysis
  15.2.6 Jiuxu Pharma Recent Developments
15.3 Ronghong Pharma
  15.3.1 Ronghong Pharma Basic Information
  15.3.2 Ronghong Pharma Neostigmine Methylsulfate Injection Product Overview
  15.3.3 Ronghong Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.3.4 Ronghong Pharma Business Overview
  15.3.5 Ronghong Pharma SWOT Analysis
  15.3.6 Ronghong Pharma Recent Developments
15.4 Xianju Pharma
  15.4.1 Xianju Pharma Basic Information
  15.4.2 Xianju Pharma Neostigmine Methylsulfate Injection Product Overview
  15.4.3 Xianju Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.4.4 Xianju Pharma Business Overview
  15.4.5 Xianju Pharma Recent Developments
15.5 Pujing Pharma
  15.5.1 Pujing Pharma Basic Information
  15.5.2 Pujing Pharma Neostigmine Methylsulfate Injection Product Overview
  15.5.3 Pujing Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.5.4 Pujing Pharma Business Overview
  15.5.5 Pujing Pharma Recent Developments
15.6 Dr. Reddy's
  15.6.1 Dr. Reddy's Basic Information
  15.6.2 Dr. Reddy's Neostigmine Methylsulfate Injection Product Overview
  15.6.3 Dr. Reddy's Neostigmine Methylsulfate Injection Product Market Performance
  15.6.4 Dr. Reddy's Business Overview
  15.6.5 Dr. Reddy's Recent Developments
15.7 Swiss
  15.7.1 Swiss Basic Information
  15.7.2 Swiss Neostigmine Methylsulfate Injection Product Overview
  15.7.3 Swiss Neostigmine Methylsulfate Injection Product Market Performance
  15.7.4 Swiss Business Overview
  15.7.5 Swiss Recent Developments
15.8 Daiichi Sankyo
  15.8.1 Daiichi Sankyo Basic Information
  15.8.2 Daiichi Sankyo Neostigmine Methylsulfate Injection Product Overview
  15.8.3 Daiichi Sankyo Neostigmine Methylsulfate Injection Product Market Performance
  15.8.4 Daiichi Sankyo Business Overview
  15.8.5 Daiichi Sankyo Recent Developments
15.9 Amneal Pharma
  15.9.1 Amneal Pharma Basic Information
  15.9.2 Amneal Pharma Neostigmine Methylsulfate Injection Product Overview
  15.9.3 Amneal Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.9.4 Amneal Pharma Business Overview
  15.9.5 Amneal Pharma Recent Developments
15.10 Amphastar Pharmaceuticals
  15.10.1 Amphastar Pharmaceuticals Basic Information
  15.10.2 Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Product Overview
  15.10.3 Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Product Market Performance
  15.10.4 Amphastar Pharmaceuticals Business Overview
  15.10.5 Amphastar Pharmaceuticals Recent Developments
15.11 Amring Pharma
  15.11.1 Amring Pharma Basic Information
  15.11.2 Amring Pharma Neostigmine Methylsulfate Injection Product Overview
  15.11.3 Amring Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.11.4 Amring Pharma Business Overview
  15.11.5 Amring Pharma Recent Developments
15.12 BE Pharmaceuticals
  15.12.1 BE Pharmaceuticals Basic Information
  15.12.2 BE Pharmaceuticals Neostigmine Methylsulfate Injection Product Overview
  15.12.3 BE Pharmaceuticals Neostigmine Methylsulfate Injection Product Market Performance
  15.12.4 BE Pharmaceuticals Business Overview
  15.12.5 BE Pharmaceuticals Recent Developments
15.13 Biological E
  15.13.1 Biological E Basic Information
  15.13.2 Biological E Neostigmine Methylsulfate Injection Product Overview
  15.13.3 Biological E Neostigmine Methylsulfate Injection Product Market Performance
  15.13.4 Biological E Business Overview
  15.13.5 Biological E Recent Developments
15.14 Caplin Point Laboratories
  15.14.1 Caplin Point Laboratories Basic Information
  15.14.2 Caplin Point Laboratories Neostigmine Methylsulfate Injection Product Overview
  15.14.3 Caplin Point Laboratories Neostigmine Methylsulfate Injection Product Market Performance
  15.14.4 Caplin Point Laboratories Business Overview
  15.14.5 Caplin Point Laboratories Recent Developments
15.15 Exela Pharma
  15.15.1 Exela Pharma Basic Information
  15.15.2 Exela Pharma Neostigmine Methylsulfate Injection Product Overview
  15.15.3 Exela Pharma Neostigmine Methylsulfate Injection Product Market Performance
  15.15.4 Exela Pharma Business Overview
  15.15.5 Exela Pharma Recent Developments
15.16 Yifan Pharmaceutical
  15.16.1 Yifan Pharmaceutical Basic Information
  15.16.2 Yifan Pharmaceutical Neostigmine Methylsulfate Injection Product Overview
  15.16.3 Yifan Pharmaceutical Neostigmine Methylsulfate Injection Product Market Performance
  15.16.4 Yifan Pharmaceutical Business Overview
  15.16.5 Yifan Pharmaceutical Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 4. Global Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 5. Neostigmine Methylsulfate Injection Market Size Comparison by Region (M USD)
Table 6. Global Neostigmine Methylsulfate Injection Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neostigmine Methylsulfate Injection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neostigmine Methylsulfate Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neostigmine Methylsulfate Injection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neostigmine Methylsulfate Injection as of 2024)
Table 11. Global Market Neostigmine Methylsulfate Injection Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Neostigmine Methylsulfate Injection Manufacturing Sites and Area Served
Table 13. Manufacturers Neostigmine Methylsulfate Injection Product Type
Table 14. Global Neostigmine Methylsulfate Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neostigmine Methylsulfate Injection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Neostigmine Methylsulfate Injection Market Size Comparison by Region (M USD)
Table 26. Global Neostigmine Methylsulfate Injection Market Size by Region (2020-2033) & (M USD)
Table 27. Global Neostigmine Methylsulfate Injection Market Size Market Share by Region (2020-2033)
Table 28. Global Neostigmine Methylsulfate Injection Sales by Region (2020-2033) & (K MT)
Table 29. Global Neostigmine Methylsulfate Injection Sales Market Share by Region (2020-2033)
Table 30. North America Neostigmine Methylsulfate Injection Market Size by Country (2020-2033) & (M USD)
Table 31. North America Neostigmine Methylsulfate Injection Sales by Country (2020-2033) & (K MT)
Table 32. North America Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 33. North America Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 34. North America Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 35. North America Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2033)
Table 36. North America Neostigmine Methylsulfate Injection Sales by Application (K MT)
Table 37. North America Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 38. North America Neostigmine Methylsulfate Injection Sales (K MT) by Application (2020-2033)
Table 39. North America Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2033)
Table 40. Europe Neostigmine Methylsulfate Injection Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Neostigmine Methylsulfate Injection Sales by Country (2020-2033) & (K MT)
Table 42. Europe Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 43. Europe Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 44. Europe Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 45. Europe Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2033)
Table 46. Europe Neostigmine Methylsulfate Injection Sales by Application (K MT)
Table 47. Europe Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 48. Europe Neostigmine Methylsulfate Injection Sales (K MT) by Application (2020-2033)
Table 49. Europe Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 53. Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 54. Asia-Pacific Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Application (K MT)
Table 57. Asia-Pacific Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 58. Asia-Pacific Neostigmine Methylsulfate Injection Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2025)
Table 60. South America Neostigmine Methylsulfate Injection Market Size by Country (2020-2033) & (M USD)
Table 61. South America Neostigmine Methylsulfate Injection Sales by Country (2020-2033) & (K MT)
Table 62. South America Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 63. South America Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 64. South America Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 65. South America Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2033)
Table 66. South America Neostigmine Methylsulfate Injection Sales by Application (K MT)
Table 67. South America Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 68. South America Neostigmine Methylsulfate Injection Sales (K MT) by Application (2020-2033)
Table 69. South America Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 73. Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 74. Middle East and Africa Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Application (K MT)
Table 77. Middle East and Africa Neostigmine Methylsulfate Injection Market Size by Application (M USD)
Table 78. Middle East and Africa Neostigmine Methylsulfate Injection Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Neostigmine Methylsulfate Injection Market Size (M USD) by Application (2020-2033)
Table 80. Global Neostigmine Methylsulfate Injection Production (K MT) by Region(2020-2025)
Table 81. Global Neostigmine Methylsulfate Injection Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Neostigmine Methylsulfate Injection Revenue Market Share by Region (2020-2025)
Table 83. Global Neostigmine Methylsulfate Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Neostigmine Methylsulfate Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Neostigmine Methylsulfate Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Neostigmine Methylsulfate Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Neostigmine Methylsulfate Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Neostigmine Methylsulfate Injection Sales by Type (K MT)
Table 89. Global Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Table 90. Global Neostigmine Methylsulfate Injection Sales (K MT) by Type (2020-2033)
Table 91. Global Neostigmine Methylsulfate Injection Sales Market Share by Type (2020-2033)
Table 92. Global Neostigmine Methylsulfate Injection Market Size (M USD) by Type (2020-2033)
Table 93. Global Neostigmine Methylsulfate Injection Market Size Share by Type (2020-2033)
Table 94. Global Neostigmine Methylsulfate Injection Sales (K MT) by Application
Table 95. Global Neostigmine Methylsulfate Injection Market Size by Application(M USD)
Table 96. Global Neostigmine Methylsulfate Injection Sales by Application (2020-2033) & (K MT)
Table 97. Global Neostigmine Methylsulfate Injection Sales Market Share by Application (2020-2033)
Table 98. Global Neostigmine Methylsulfate Injection Market Size by Application (2020-2033) & (M USD)
Table 99. Global Neostigmine Methylsulfate Injection Market Share by Application (2020-2033)
Table 100. Global Neostigmine Methylsulfate Injection Sales Growth Rate by Application (2020-2033)
Table 101. SPH Basic Information
Table 102. SPH Neostigmine Methylsulfate Injection Product Overview
Table 103. SPH Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. SPH Business Overview
Table 105. SPH SWOT Analysis
Table 106. SPH Recent Developments
Table 107. Jiuxu Pharma Basic Information
Table 108. Jiuxu Pharma Neostigmine Methylsulfate Injection Product Overview
Table 109. Jiuxu Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Jiuxu Pharma Business Overview
Table 111. Jiuxu Pharma SWOT Analysis
Table 112. Jiuxu Pharma Recent Developments
Table 113. Ronghong Pharma Basic Information
Table 114. Ronghong Pharma Neostigmine Methylsulfate Injection Product Overview
Table 115. Ronghong Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Ronghong Pharma Business Overview
Table 117. Ronghong Pharma SWOT Analysis
Table 118. Ronghong Pharma Recent Developments
Table 119. Xianju Pharma Basic Information
Table 120. Xianju Pharma Neostigmine Methylsulfate Injection Product Overview
Table 121. Xianju Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Xianju Pharma Business Overview
Table 123. Xianju Pharma Recent Developments
Table 124. Pujing Pharma Basic Information
Table 125. Pujing Pharma Neostigmine Methylsulfate Injection Product Overview
Table 126. Pujing Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pujing Pharma Business Overview
Table 128. Pujing Pharma Recent Developments
Table 129. Dr. Reddy's Basic Information
Table 130. Dr. Reddy's Neostigmine Methylsulfate Injection Product Overview
Table 131. Dr. Reddy's Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Dr. Reddy's Business Overview
Table 133. Dr. Reddy's Recent Developments
Table 134. Swiss Basic Information
Table 135. Swiss Neostigmine Methylsulfate Injection Product Overview
Table 136. Swiss Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Swiss Business Overview
Table 138. Swiss Recent Developments
Table 139. Daiichi Sankyo Basic Information
Table 140. Daiichi Sankyo Neostigmine Methylsulfate Injection Product Overview
Table 141. Daiichi Sankyo Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Daiichi Sankyo Business Overview
Table 143. Daiichi Sankyo Recent Developments
Table 144. Amneal Pharma Basic Information
Table 145. Amneal Pharma Neostigmine Methylsulfate Injection Product Overview
Table 146. Amneal Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Amneal Pharma Business Overview
Table 148. Amneal Pharma Recent Developments
Table 149. Amphastar Pharmaceuticals Basic Information
Table 150. Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Product Overview
Table 151. Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Amphastar Pharmaceuticals Business Overview
Table 153. Amphastar Pharmaceuticals Recent Developments
Table 154. Amring Pharma Basic Information
Table 155. Amring Pharma Neostigmine Methylsulfate Injection Product Overview
Table 156. Amring Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Amring Pharma Business Overview
Table 158. Amring Pharma Recent Developments
Table 159. BE Pharmaceuticals Basic Information
Table 160. BE Pharmaceuticals Neostigmine Methylsulfate Injection Product Overview
Table 161. BE Pharmaceuticals Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. BE Pharmaceuticals Business Overview
Table 163. BE Pharmaceuticals Recent Developments
Table 164. Biological E Basic Information
Table 165. Biological E Neostigmine Methylsulfate Injection Product Overview
Table 166. Biological E Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Biological E Business Overview
Table 168. Biological E Recent Developments
Table 169. Caplin Point Laboratories Basic Information
Table 170. Caplin Point Laboratories Neostigmine Methylsulfate Injection Product Overview
Table 171. Caplin Point Laboratories Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Caplin Point Laboratories Business Overview
Table 173. Caplin Point Laboratories Recent Developments
Table 174. Exela Pharma Basic Information
Table 175. Exela Pharma Neostigmine Methylsulfate Injection Product Overview
Table 176. Exela Pharma Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Exela Pharma Business Overview
Table 178. Exela Pharma Recent Developments
Table 179. Yifan Pharmaceutical Basic Information
Table 180. Yifan Pharmaceutical Neostigmine Methylsulfate Injection Product Overview
Table 181. Yifan Pharmaceutical Neostigmine Methylsulfate Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Yifan Pharmaceutical Business Overview
Table 183. Yifan Pharmaceutical Recent Developments
List of Figures
Figure 1. Product Picture of Neostigmine Methylsulfate Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neostigmine Methylsulfate Injection Market Size (M USD), 2024-2033
Figure 5. Global Neostigmine Methylsulfate Injection Market Size (M USD) (2020-2033)
Figure 6. Global Neostigmine Methylsulfate Injection Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neostigmine Methylsulfate Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neostigmine Methylsulfate Injection Product Life Cycle
Figure 13. Neostigmine Methylsulfate Injection Sales Share by Manufacturers in 2024
Figure 14. Global Neostigmine Methylsulfate Injection Revenue Share by Manufacturers in 2024
Figure 15. Neostigmine Methylsulfate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neostigmine Methylsulfate Injection Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neostigmine Methylsulfate Injection Revenue in 2024
Figure 18. Industry Chain Map of Neostigmine Methylsulfate Injection
Figure 19. Global Neostigmine Methylsulfate Injection Market PEST Analysis
Figure 20. Global Neostigmine Methylsulfate Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Neostigmine Methylsulfate Injection Market Size by Region
Figure 27. Global Neostigmine Methylsulfate Injection Market Size Market Share by Region (2020-2033)
Figure 28. Global Neostigmine Methylsulfate Injection Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Neostigmine Methylsulfate Injection Market Size (M USD) by Country
Figure 33. USA Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Neostigmine Methylsulfate Injection Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Neostigmine Methylsulfate Injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Neostigmine Methylsulfate Injection Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Neostigmine Methylsulfate Injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Neostigmine Methylsulfate Injection Market Size (M USD)by Type
Figure 40. North America Neostigmine Methylsulfate Injection Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Neostigmine Methylsulfate Injection Market Size (M USD) by Country
Figure 45. Germany Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Neostigmine Methylsulfate Injection Market Size (M USD) by Type
Figure 56. Europe Neostigmine Methylsulfate Injection Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Neostigmine Methylsulfate Injection Market Size (M USD) by Country
Figure 61. China Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Neostigmine Methylsulfate Injection Market Size (M USD) by Type
Figure 72. Asia-Pacific Neostigmine Methylsulfate Injection Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Neostigmine Methylsulfate Injection Market Size (M USD) by Country
Figure 77. Brazil Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Neostigmine Methylsulfate Injection Market Size (M USD) by Type
Figure 84. South America Neostigmine Methylsulfate Injection Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Neostigmine Methylsulfate Injection Market Size (M USD) by Country
Figure 89. Saudi Arabia Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Neostigmine Methylsulfate Injection Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Neostigmine Methylsulfate Injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Neostigmine Methylsulfate Injection Market Size (M USD) by Type
Figure 100. Middle East and Africa Neostigmine Methylsulfate Injection Market Size (M USD) by Application
Figure 101. Global Neostigmine Methylsulfate Injection Production Market Share by Region (2020-2025)
Figure 102. North America Neostigmine Methylsulfate Injection Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Neostigmine Methylsulfate Injection Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Neostigmine Methylsulfate Injection Production (K MT) Growth Rate (2020-2025)
Figure 105. China Neostigmine Methylsulfate Injection Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Neostigmine Methylsulfate Injection Market Size by Type (M USD)
Figure 108. Sales Market Share of Neostigmine Methylsulfate Injection by Type (2020-2033)
Figure 109. Sales Market Share of Neostigmine Methylsulfate Injection by Type in 2024
Figure 110. Market Size Share of Neostigmine Methylsulfate Injection by Type (2020-2033)
Figure 111. Market Size Share of Neostigmine Methylsulfate Injection by Type in 2024
Figure 112. Global Neostigmine Methylsulfate Injection Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Neostigmine Methylsulfate Injection Market Size by Application(M USD)
Figure 115. Global Neostigmine Methylsulfate Injection Market Share by Application
Figure 116. Global Neostigmine Methylsulfate Injection Sales Market Share by Application (2020-2033)
Figure 117. Global Neostigmine Methylsulfate Injection Sales Market Share by Application in 2024
Figure 118. Global Neostigmine Methylsulfate Injection Market Share by Application (2020-2033)
Figure 119. Global Neostigmine Methylsulfate Injection Market Share by Application in 2024
Figure 120. Global Neostigmine Methylsulfate Injection Sales Growth Rate by Application (2020-2033)